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Objective: To investigate the use of DNA amplification by the polymerase chain reaction (PCR) for the detection of 
Mycobacteriurn tuberculosis directly in human respiratory specimens. 
Methods: The PCR assay employed was the Amplicor M. tuberculosis Test (Roche Diagnostics, Switzerland), which 
uses the 16s rDNA as the target template. Nine hundred and sixty samples from 741 patients in two clinical microbiology 
laboratories in Norway and Sweden were processed by routine culture analysis and PCR. 
Results: Of the 56 specimens containing cultivatable M. tuberculosis, 49 (87.5%) were detected by PCR. Among the 904 
culture-negative specimens, 897 samples were negative also by  PCR and seven (0.8%) were positive by PCR. In 
comparison with culture, the sensitivity, specificity, and positive and negative predictive values of PCR were 91.7%, 
99.6%, 94.2% and 99.4% for laboratory 1 and 80.0%, 98.7%. 76.2% and 99.0% for laboratory 2, respectively. For both 
laboratories combined the values were 87.5%. 99.2%. 87.5% and 99.2%. 
Conclusions: These results indicate that multiple (two or three) respiratory samples from each patient should be tested, 
to allow sufficient accuracy in detecting M. tuberculosis in the specimens. Still, the labor-intensive format of this test 
necessitates strong clinical indications and patient prioritization to  provide a service feasible within the current limits of 
routine laboratories. 
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INTRODUCTION 
There is clearly a demand for more rapid and reliable 
laboratory methods for the diagnosis of Mycobacterium 
tuberculosis infections for public health and therapeutic 
reasons [l]. The introduction of the radiometric 
BACTEC system represents a major improvement in 
the cultivation of mycobacteria by providing rapid 
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detection and a high recovery rate of niycobacterial 
cultures [2,3]. Species-specific nucleic acid probes have 
significantly improved the opportunity for rapid 
confirmation of culture results for several mycobacterial 
species [4]. Still, days to weeks may be required for 
suficient growth for identification. The use of the 
polymerase chain reaction (PCR) for species identifica- 
tion of mycobacteria, particularly A4. tuberculosis, from 
early BACTEC cultures has been favorably explored 
[5,61. 
Several groups have previously validated PCR 
assays for the identification of M.  tuberculosis directly in 
clinical specimens [7-111. Several nucleic acid targets 
have rendered sufficient sensitivity and representative 
species-specific differentiation, such as the 16s rKNA 
gene 112,131, IS elements (14--161, and the genes 
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encoding the 32-kDa and 65-kDa proteins [7,17]. 
Nucleic acid amplification techniques other than PCR,  
such as transcription-mediated amplification [ 3.4,18] 
and, more recently, strand displacement [19] and Q- 
beta-replicase probe amplification assays [20], are also 
being widely used. 
We evaluated the Amplicor P C R  assay (R.oche, 
Switzerland) for detection of M.  tuberculosis directly in 
respiratory specimens. The target DNA to be amplified 
was the mycobacterial 16s rDNA signature region 
[13,21]. The aim of our study was to establish whether 
this test was useful for direct detection of M.  tuberculosis 
in respiratory samples in Scandinavian laboratories, one 
in Norway and one in Sweden. 
MATERIALS AND METHODS 
Material 
All routine clinical specimens submitted for cultivation 
of mycobacteria were processed by standard pro- 
cedures. The specimens in laboratory I were decon- 
taminated by the N-acetyl-L-cysteine/NaOH method 
[22]. Two volumes of NALC/NaOH solution (2% 
NaOH, 1.45% sodium-citrate, 0.5% N-acetyl-L- 
cysteine) were mixed well with the specimen and 
allowed to digest for 15 to 30 min at room temperature. 
Ten volumes of 10 mM phosphate buffer (pH 6.8) were 
added for dilution, before centrifugation at 3000,g for 
15 min. In laboratory 2 the samples were decon- 
taminated by the sodium lauryl sulfate method [23] and 
centrifuged at 35008 for 30min. Sediments were 
resuspended in 3 to 5 ml of phosphate-buffered saline. 
Smears were prepared, stained according to Ziehl- 
Nielsen or with auramine, and examined for acid-fast 
bacilli (AFB) by microscopy. Five hundred and eighty- 
two sputum samples and 378 bronchioalveolar lavage 
(BAL) samples from 741 patients were processed. Five 
hundred and forty-four samples were investigated by 
laboratory 1 and 416 by laboratory 2. 
Culture protocol 
BACTEC Middlebrook 12B vials (Becton Dickinson 
Diagnostic Instruments, Sparks, Md, USA) [2,3] were 
inoculated with 0.5 mL of each specimen. The 12B 
vials were monitored by using the BACTEC 460 
radiometric reader (Becton Dickinson Diagnostic 
Instruments) on a regular basis for 6 weeks. Once a 12B 
vial attained a growth index (GI) of >= loo ,  the 
presence of AFB was confirmed by Ziehl-Nilsen 
staining. Laboratory 2 inoculated each sample on 
Lowenstein-Jenssen (LJ) medium. The P C R  assay was 
incorporated into the laboratory routine without any 
change in practices, and specimens were processed 5 to 
6 daydweek. 
Culture identification 
Hybridization assays were performed directly on lysed 
AFB using commercially available nucleic acid probes 
for the M .  tuberculosis complex and M.  avium-intra- 
cellulare (MAC) (Accuprobe, Gen-Probe, San Diego, 
CA, USA) [4]. Mycobacterial species other than the M. 




One hundred microliters of the decontaminated 
sputum or BAL was added to 500 pL of Tris-HC1 with 
1% Triton X-100 and 0.05% sodium azide, mixed and 
centrifuged at 12 ,500~  for 10 min. The supernate was 
carefully removed, and 100 pL of the lysis solution 
containing 1% Triton X-100, 0.4% sodium hydroxide 
and 0.05% sodium azide was added. The pellet was 
dissolved by vortex mixing and incubated at 60 "C for 
45 min. After centrifugation, 100 pL Tris-HC1 with 
0.05% sodium azide was added. One positive control 
containing M .  tuberculosis DNA and three negative 
buffer controls were included in each experiment for 
reference purposes. 
PCR amplification reaction 
Genus-specific primers KY18 and KY75 derived to 
correspond to a highly conserved region of the 16s 
rRNA gene (rDNA) of mycobacteria were used to 
amplify a 584-base-pair fragment (bases 15 to 598 of 
the M. tuberculosis 16s rDNA sequence, accession no. 
52917 in Genbank). Fifty microliters of each sample 
were added to 50 pL of P C R  reaction mixture 
(Amplicor, Roche, Basel, Switzerland) containing 
10 mM Tris-HC1,50 mh4 KCl, 2 mM MgC12,200 pM 
concentrations of each deoxynucleotide triphosphate 
(dATP, dCTP, dGTP and dUTP), 0.001% (w/v) 
gelatin, uracil-N-glycosylase (UNG), biotinylated 
primers, and 0.5 U of Ampli-Taq polymerase (Perkin- 
Elmer Cetus, Nonvalk, CT, USA). Each sample was 
first heated a t  50 "C for 2 min, and then amplified in 
two cycles of 20 s at 98"C, 20 s at 62°C and 45 s at 
72"C, and then in 35 cycles of 20 s at 94"C, 20 s at 
62°C and 45 s at 72°C in a thermal cycler (Perkin 
Elmer Cetus TA9600). dUTP, instead of dTTF', was 
used as a substrate for U N G  in order to prevent 
carryover of the amplified DNA [24]. Finally, samples 
were heated at 72 "C for 5 min until further processing 
to complete the initiated DNA polymerase activity 
and not allow UNG, which could have survived the 
extensive heating, to have an effect on dUTP- 
containing PCR products. 
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Hybridization reaction 
After the PCK amplification process, the amplified 
products were chemically denatured and added to a 
microwell plate containing a bound, M .  tubevculosis- 
specific oligonucleotide probe, KY 172T3. This probe 
was selected from the hypervariable region of the 16s 
rRNA gene 13,211. The biotin-labeled P C R  products 
were then hybridized to the probe and thus 'captured'. 
Detection reaction 
After washing to remove unbound material, an avidin- 
horseradish peroxidase (Av-HKP) conjugate was added 
to the plate. After washing to remove the unbound 
conjugate, the bound Av-HKP was reacted with 
peroxide (H202) and tetraniethylbenzidine (TMB) to 
form a color complex. The reaction was stopped by the 
addition of weak acid. The optical density a t  450 nni 
was measured in an automated microwell plate reader 
and the results were compared to the cut-off value of 
0.350. A clinical specimen with an reading equal 
to or greater than 0.35 is positive, and a specimen with 
a reading less than 0.35 is negative for the presence of 
M .  tubwrulosis DNA. 
Chemical prevention of PCR product contamination 
The recommended procedures to prevent false-positive 
reactions as a result of target or amplified product 
contamination were followed. 
Detection of mycobacteria by culture 
In total, 88 specimens were positive by culture (9.2%) 
(Table 1 ) .  O f  these, 56 (5.80/;,) were M.  tuberculosis 
isolates from 33 patients. Moreover, 15 isolates of 
MAC, 12 M .  malinoense, two M .  clielouae, and one M. 
xcnopi were detected. 
Table 1 
I'CR in detection of M .  ruhevcrrlosk in respiratory speciniens 
in Scandinavia. The nunibers for laboratory 1 and 2 are 
given on the upper line, and thc total numbcrs for both 
laboratorics are given in bold type 
Comparison of results obtained by culture and 
Culture Culture M t b  Culture Mtb- Total 
M t b f  Culture MOTT- Culture MOTT+ 
I'CRf 33+16 2" .i o+n 35+22 
49 7 0 56 
PClI-  3 h + 4  487 + 378 19+13 509+395 
7 865 32 904 
Total 56 872 32 960 
.'Other s.iinplcs froin these two patients wcrc M. tcrbercrtlosi~ culture 
po"t1ve. 
"lieteyting by PCIX (AmpliCor) gave a positive result in one of 
thew samples; PCK confirmation testing by Roche in Hasel (blind 
teTtirig) gave poqitive results in the remaining two wiiples. 
Detection of M. tuberculosis by PCR 
The same 960 respiratory specimens were tested for 
presence of M. tubcrc~losis by thy nucleic acid aniplific- 
ation method (PCR). In total, 49 of the 56 specimens 
which yielded M.  tuberculosis by culture were positive 
for M .  tubevculosis DNA by P C R  (Table 1). PCK was 
positive for an additional seven specinienr from four 
patients, which were negative by culture. Based on the 
findings in Table 1,  the overall sensitivity, specificity, 
and positive predictive and negative predictive values of 
this particular P C R  test in comparison with culture 
were 87.5%1, 99.2'3'1, 87.5% and 99.294, respectively 
(Table 2). The values of the P C R  test were 91.7%, 
99.6%, 94.2% and 99.4% for laboratory 1 and 80.096, 
98.7%, 76.2% and 99.0% for laboratory 2, respectively 
(Table 2). 
N o  positive result for the M .  tuberculosis complex 
was obtained by the PCK system for the specimens 
which were positive for atypical niycobacteria or other 
bacterial species grown in the BACTEC 12B or LJ 
media. Four patients whose sputum specimens were 
culture negative, but M. tuberculosis PCR-positive, had 
other PCR-positive samples, a past history of tubercu- 
losis and/or clinical response to recent antituberculosis 
chemotherapy. 
DISCUSSION 
In comparison with culture, the sensitivity of PCK was 
91.7% for laboratory 1 and 80.0% for laboratory 2, 
respectively (Tables 1 and 2). In comparison with 
previously published studies for direct detection of L\f. 
tuberculosis by PCR,  other groups have found that the 
sensitivity of their P C R  assays when cornpared with 
culture ranged from 82% to 94% [7,14-171. Seven 
samples in five patients were 2.I. tubevc-trloris culture 
negative and P C R  positive and can as such be strictly 
regarded as false positive. But when other hctors are 
taken into account for evaluating the patient as ''if. 
tcrbcvculosis positive' by having other samples poyitive 
by culture and/or P C R  or other factors indicating 
tuberculosis, most of this specificity problem is 
resolved. 
Table 2 
value and negative predictive value of the PCR tmt as 
compared to culture, based on the results in Tablc 1 
The sensitivity, specificit); and positive predictivc 
Positivc Negative 
Sensitivity Specificity prcdictivc predictivc 
Laboratory (%) (9%) value ('H,) v.iluc ('HI) 
Lhoratory 1 91.7 99.6 94.2 09 1 
Laboratory 2 80.0 98.7 76.2 09.0 
Laboratories 
1 and 2 87.5 99.2 87.5 90.2 
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Different decontamination procedures may account 
for the major part of the discrepant sensitivity in 
the two laboratories. Laboratory 1 used the NALC 
decontamination procedure, while laboratory 2 used 
the sodium dodecylsulfate (SDS) method. The NALC 
procedure is clearly the decontamination method 
recommended by the Amplicor manufacturing 
company and for P C R  and other amplification 
techniques [14,15,18]. The higher sensitivity of P C R  
in comparison with culture for laboratory 1 could also 
be due to less optimized culture techniques than in 
laboratory 2, laboratory 1 using only BACTEC 
detection and not including solid media [3]. Possibly, 
recently documented batches of BACTEC vials with 
reduced performance in cultivating both M.  tuberculosis 
and MOTT might be involved 1251. Other factors 
include the time elapsed between sampling and 
processing, sample handling, and the technical quality 
of the sample preparation, lysis and PCK set-up. The 
samples examined by P C R  by laboratory 2 were 
transported after decontamination and sample 
preparation and frozen at -70 "C before P C R  analysis. 
The sample lysis and pretreatment procedure with 
Triton X-100 and optimized buffering clearly facilitates 
direct detection of M. tuberculosis by PCR.  The U N G  
enzyme inactivates up to lo9 copies of uracil- 
containing M. tuberculosis amplified DNA [24]. This 
reduced the likelihood of false-positive results arising 
due to contamination with pre-existing P C R  products. 
Furthermore, the inclusion of the hybridization event 
ensured that only M .  tuberculosis-specific P C R  products 
were detected, increasing the overall specificity of the 
test. These actions, in addition to careful laboratory 
precautions in sample processing and work habits, have 
now minimized the occurrence of false-positive PCR 
results. 
Factors lowering the sensitivity of P C R  are 
interfering substances present in clinical specimens 
[7,11,15] and inadequate amounts of the microbial 
DNA to be detected. An uneven distribution of 
bacteria or DNA, even after lysis of the material, as may 
particularly apply to mucous material in sputum, may 
cause an arbitrary sampling effect. In our hands, the 
PCR assay worked just as well directly on respiratory 
specimens which were not subjected to decontamin- 
ation (unpublished results). The elimination of factors 
inhibitory for P C R  in clinical specimens remains a 
challenge in the use and acceptance of all amplification 
assays in the diagnostic setting. Certainly, the inclusion 
of a positive amplification control test is useful to assess 
the inhibiting factors which may be present in clinical 
material. 
Despite promising results of numerous published 
reports, the routine use of P C R  to detect M. tuberculosis 
directly in clinical specimens has been hampered for a 
variety of reasons, such as contamination, expense, and 
lack of sensivity and/or specificity [7,9-11,13,15,17]. 
In addition, the routine use of P C R  in the clinical 
laboratory sets limitations because of the complex pro- 
cedures required for amplification, such as cumbersome 
sample preparation and detection methods. 
Still, using P C R  in the identification of M. 
tuberculosis directly in clinical samples offers unique 
improvements in this diagnostic field. This P C R  assay 
offers a sensitive and specific test for M. tuberculosis 
performed within 5 to 6 h. More automation and lower 
assay expenses are required. For the future, this and 
other amplification techniques can facilitate the direct 
detection of the infecting agent and its antibiotic 
susceptibility pattern [26], as well as epidemiological 
mapping [27]. Potentially, all of these goals can be 
achieved in one single multiplex assay. 
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